New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
15:23 EDTURS, KING, LQ, JDSU, JKHY, CREE, PE, MYGN, FOSL, VSATNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Cree (CREE), consensus 41c; King Digital (KING), consensus 59c; Fossil Group (FOSL), consensus 96c; Jack Henry (JKHY), consensus 60c; URS Corporation (URS), consensus 74c; Myriad Genetics (MYGN), consensus 46c; JDS Uniphase (JDSU), consensus 13c; ViaSat (VSAT), consensus 15c; Parsley Energy (PE), consensus 9c; La Quinta (LQ), consensus 11c.
News For CREE;KING;FOSL;JKHY;URS;MYGN;JDSU;VSAT;PE;LQ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 19, 2015
05:23 EDTVSATViaSat selected by Gulfstream as sole source Ku-Band equipment supplier
Subscribe for More Information
May 18, 2015
13:41 EDTCREECree sees Franco Plastina becoming CEO of Power and RF business post-IPO
In a regulatory filing earlier, Cree reported that on May 5, its board of directors appointed Franco Plastina as the company’s interim EVP, Power & RF, effective June 8. The company additionally noted that it expects Plastina to serve as CEO of Cree Power & RF Division upon the completion of its previously announced initial public offering. Plastina is presently a member of the company’s board, on which he has served since December 2007. Since May 2012, Plastina has served as president and founder of Arc & Company, an advisory and angel investment firm.
10:37 EDTKINGOptions with decreasing implied volatility
Options with decreasing implied volatility: NLNK ARWR CTRP ZIOP CLNE ARIA VHC AOL KING XON PEIX
08:35 EDTCREECree submits registration statement for IPO of Power and RF Business
Cree announced that Cree’s wholly owned Power and RF subsidiary has submitted a draft registration statement on a confidential basis to the SEC for a potential initial public offering of the subsidiary’s class A common stock. The type and number of shares of stock to be sold and the price range for the proposed initial public offering has not yet been determined, although Cree intends to remain the majority stockholder of the subsidiary post offering. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions. The Power and RF subsidiary is raising capital to invest directly in the business to support targeted future growth. The offering would enable Cree management to focus on Cree’s LED and Lighting businesses, while also creating a dedicated focus on the Power and RF business. The company believes that this transaction should allow Cree shareholders to better realize the full value of both businesses, the company said.
07:27 EDTCREEJPMorgan to hold a conference
Subscribe for More Information
May 15, 2015
12:42 EDTPEParsley Energy upgraded to Buy from Hold at Clarkson Capital
Subscribe for More Information
10:28 EDTMYGNMAC updates positive for NanoString, Myriad, Invitae, QIAGEN, says Leerink
Leerink said that coverage updates posted yesterday by Medicare Administrative Contractors were favorable for NanoString (NSTG), Myriad Genetics (MYGN), Invitae (NVTA) and QIAGEN (QGEN). The firm has Outperform ratings on NanoString and Invitae and Market Perform rating on the other two stocks listed.
10:20 EDTKINGOptions with decreasing implied volatility
Options with decreasing implied volatility: NLNK ARWR CTRP RAX KING AOL WPZ RL Z MBI
09:11 EDTKINGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bsquare (BSQR), up 34.2%... Applied Materials (AMAT), up 3.2%. ALSO HIGHER: Trillium Therapeutics (TRIL), up 13% after being initiated with an Outperform at Oppenheimer... Pernix Therapeutics (PTX), up 7.4% after announcing FDA approval of Treximet for use in pediatric patients... Advaxis (ADXS), up 4.4% after being initiated with a Buy at Jefferies... Netflix (NFLX), up 3.3% following a Bloomberg report that the company is in talks to enter China's online video market... Inovalon (INOV), up 2.9% after being upgraded to Buy from Neutral at Goldman. DOWN AFTER EARNINGS: El Pollo LoCo (LOCO), down 12.8%... King Digital (KING), down 8.3%. ALSO LOWER: PlasmaTech (PTBI), down 5.4% after filing to sell 1.93M shares for selling stockholders... Paycom Software (PAYC), down 7% after 8M share Spot Secondary priced at $36.25... Keurig Green Mountain (GMCR), down 5.9% after Keurig Kold investor presentation... 3D Systems (DDD), down 2.4% after CFO transition... Celladon (CLDN), down 5.1% after the CEO says that the company is evaluating strategic options.
07:09 EDTMYGNMyriad Genetics presents clinical data for Prolaris test
Myriad Genetics presented clinical data for its Prolaris test at the 2015 American Urological Association, or AUA, Annual Meeting being held May 15-19 in New Orleans, La. The results highlighted and underscored the significant ability of the Prolaris test to help physicians improve care for men diagnosed with prostate cancer. In this pioneering study, Myriad presented important new clinical validation data that establishes an active surveillance, or AS, threshold for men with localized prostate cancer. Specifically, the AS threshold is a composite of the Prolaris test score and clinicopathologic features. In the validation data featured at AUA, the pre-defined AS threshold was evaluated in 765 conservatively managed men, and the clinical endpoint was 10-year risk of prostate cancer mortality. The results showed that at the AS threshold, the predicted 10-year survival rate of prostate cancer patients was 97%. Conversely, there was a three percent risk of 10-year, prostate-specific mortality. Importantly, however, there were no observed prostate cancer-specific deaths over 10 years among men whose scores fell below the AS threshold. Additionally, a separate analysis of 4,218 patients was performed to determine what percentage of patients who were clinically tested with Prolaris would be candidates for active surveillance based on the validated AS threshold. Of this commercial cohort, 36% qualified for active surveillance based on their clinical features alone. However, when the Prolaris test was added to the clinical risk assessment, 60% of these patients fell below the AS threshold, representing a significant increase in the total number of candidates who may be eligible for active surveillance.
May 14, 2015
19:02 EDTKINGOn The Fly: After Hours Movers
Subscribe for More Information
16:46 EDTKINGKing Digital falls sharply after earnings
Shares are down over 11% in the extended session to $13.39. At that price next support is at $12.56. Resistance is at $13.91.
16:14 EDTKINGKing Digital sees Q2 gross bookings $490M-$520M
Subscribe for More Information
16:13 EDTKINGKing Digital reports Q1 adjusted EPS 61c, consensus 53c
Subscribe for More Information
15:01 EDTKINGNotable companies reporting after market close
Subscribe for More Information
14:06 EDTKINGKing Digital May volatility elevated into Q1 and outlook
King Digital May call option implied volatility is at 220, June is at 58, August is at 54; compared to its 90-average of 54, suggesting large near term price movement in to the expected release of Q1 results on May 15.
May 13, 2015
18:47 EDTMYGNMyriad Genetics to present data from 19 studies at 2015 ASCO meeting
Subscribe for More Information
08:36 EDTJDSUJDSU signs definitive agreement with Amada Holdings
Subscribe for More Information
07:16 EDTVSATMoffett Nathanson to hold a summit
Subscribe for More Information
07:10 EDTVSATB. Riley to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use